Elisabeth Palazzo

Summary

Country: France

Publications

  1. doi request reprint IgG4-related disease
    Elisabeth Palazzo
    Service de Rhumatologie, Hopital Bichat, Paris, France Electronic address
    Joint Bone Spine 81:27-31. 2014
  2. pmc Body mass index influences the response to infliximab in ankylosing spondylitis
    Sebastien Ottaviani
    Rheumatology Department, AP HP, Paris Diderot, Sorbonne Paris Cité University, Bichat Claude Bernard Hospital, 46 rue Henri Huchard, Paris, 75018, France
    Arthritis Res Ther 14:R115. 2012
  3. doi request reprint Progressive multifocal leukoencephalopathy in autoimmune diseases
    Elisabeth Palazzo
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 79:351-5. 2012
  4. pmc Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
    Pascale Nicaise Roland
    Immunology and Haematology Department, Bichat Claude Bernard Teaching Hospital, AP HP, Paris Cedex 18, France
    Arthritis Res Ther 10:R142. 2008
  5. pmc Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus
    Olivier C Meyer
    Rheumatology Unit, Bichat Hospital, APHP, 75018 Paris, France
    Arthritis Res Ther 11:R87. 2009

Collaborators

  • Gilles Hayem
  • Philippe Dieude
  • Sebastien Ottaviani
  • Olivier Meyer
  • Olivier C Meyer
  • Pascale Nicaise Roland
  • Yannick Allanore
  • Andre Kahan
  • Florence Tubach
  • Chantal Job-Deslandre
  • Marine Forien
  • Anaïs Gardette
  • Blandine Pasquet
  • Marine Meunier
  • Sylvie Chollet-Martin
  • Pascale Nicaise-Roland
  • Sabine Grootenboer-Mignot
  • Nolwenn Cadoudal
  • Alessandra Bruns
  • Sylvie Chollet Martin
  • Margarita Hurtado
  • Sabine Grootenboer Mignot

Detail Information

Publications5

  1. doi request reprint IgG4-related disease
    Elisabeth Palazzo
    Service de Rhumatologie, Hopital Bichat, Paris, France Electronic address
    Joint Bone Spine 81:27-31. 2014
    ..IgG4-related disease is not an autoimmune condition related to IgG4 autoantibodies, and neither does it involve immune complexes. Specific joint involvement has been reported in a very small number of patients. ..
  2. pmc Body mass index influences the response to infliximab in ankylosing spondylitis
    Sebastien Ottaviani
    Rheumatology Department, AP HP, Paris Diderot, Sorbonne Paris Cité University, Bichat Claude Bernard Hospital, 46 rue Henri Huchard, Paris, 75018, France
    Arthritis Res Ther 14:R115. 2012
    ..The aim of this study was to determine whether body mass index (BMI) affects response to infliximab (IFX) in ankylosing spondylitis (AS) patients...
  3. doi request reprint Progressive multifocal leukoencephalopathy in autoimmune diseases
    Elisabeth Palazzo
    Service de Rhumatologie, Hopital Bichat, 46, rue Henri Huchard, 75018 Paris, France
    Joint Bone Spine 79:351-5. 2012
    ..In patients with lupus, the risk of PML is higher than in RA (4/100,000) and 40% of cases of PML occur during low-dose glucocorticoid therapy without immunosuppressive therapy...
  4. pmc Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
    Pascale Nicaise Roland
    Immunology and Haematology Department, Bichat Claude Bernard Teaching Hospital, AP HP, Paris Cedex 18, France
    Arthritis Res Ther 10:R142. 2008
    ..The aims of this study were to evaluate the usefulness of anti-MCV for diagnosing RA in anti-CCP-negative patients and to monitor anti-MCV titres during infliximab therapy for RA...
  5. pmc Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus
    Olivier C Meyer
    Rheumatology Unit, Bichat Hospital, APHP, 75018 Paris, France
    Arthritis Res Ther 11:R87. 2009
    ..Autoantibodies against C1q correlate with lupus nephritis. We compared titers of anti-C1q and anti-dsDNA in 70 systemic lupus erythematosus patients with (n = 15) or without (n = 55) subsequent biopsy-proven lupus nephritis...